De novo manifestations during adalimumab treatment in Behçet's syndrome.
Esatoglu SN, Sonmez O, Ucar D, Kaymaz E, Ozguler Y, Ugurlu S, Seyahi E, Melikoglu M, Fresko I, Hamuryudan V, Uygunoglu U, Kutlubay Z, Hatemi AI, Celik AF, Hatemi G.
Esatoglu SN, et al.
Rheumatology (Oxford). 2024 Aug 7:keae416. doi: 10.1093/rheumatology/keae416. Online ahead of print.
Rheumatology (Oxford). 2024.
PMID: 39110537